Clinical trial
S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas…
NCT00049400 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00049400 |
|---|---|
| Title | S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction |
| Official title | A Phase I Pharmacokinetic Study Of Epothilone B Analogue BMS-247550 (NSC 710428D) In Patients With Advanced Malignancies And Varying Levels Of Liver Dysfunction |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | BMS-247550 |
| Enrollment | 78 |
| Start date | Oct 1, 2003 |
| Primary completion | Sep 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 3, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: